# US 2022/0325353 A1 · Methods for the detection of genomic copy changes in dna samples

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0325353 A1
- Document ID: US20220325353A1
- Status: Published application
- Kind: A1
- Application number: 17/586,143
- Filed: 2022-01-27
- Published: 2022-10-13
- Earliest claimed: 2016-08-25
- Assignees: Resolution Bioscience, Inc.
- Applicants: Resolution Bioscience, Inc.
- Inventors: Christopher RAYMOND; Lee LIM; Jennifer HERNANDEZ
- Web page: https://patentgrep.com/patent/US20220325353A1

## CPC

- A61P 35/00: Antineoplastic agents
- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- C12Q 1/68: involving nucleic acids
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 1/6869: Methods for sequencing
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 20/10: Ploidy or copy number detection
- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G16B 20/40: Population genetics; Linkage disequilibrium
- G16B 25/10: Gene or protein expression profiling; Expression-ratio estimation or normalisation
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B 30/10: Sequence alignment; Homology search
- C12Q 1/6851: Quantitative amplification
- C12Q 2525/191: incorporating an adaptor
- C12Q 2545/114: involving a quantitation step
- C12Q 2563/159: Microreactors, e.g. emulsion PCR or sequencing, droplet PCR, microcapsules, i.e. non-liquid containers with a range of different permeability's for different reaction components
- C12Q 2563/179: the label being a nucleic acid
- C12Q 2600/156: Polymorphic or mutational markers
- C40B 40/08: Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
- G01N 2570/00: Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
- G01N 2800/7028: Cancer
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention includes compositions and methods useful for the detection of a mutational change. SNP, translocation, inversion, deletion, change in copy number, or other genetic variation within a sample of cellular genomic DNA or cell-free DNA (cfDNA). In some embodiments, the compositions and methods of the present invention provide an extremely high level of resolution that is particularly useful in detecting copy number variations in a small fraction of the total cfDNA from a biological sample (e.g., blood).

## Claims

### Claim at position 1

1-105. (canceled)

### Claim 106

A kit comprising a set of adaptors,
wherein each adaptor of the set of adaptors comprises a sample tag region selected from a pool of unique sample tag regions, wherein the pool is selected from a plurality of pools, and wherein the selected pool is unique to a test sample;
wherein the test sample comprises a plurality of DNA fragments.

### Claim 107 (depends on 106)

The kit of claim 106, wherein each adaptor of the set of adaptors is a DNA polynucleotide that comprises (i) an amplification region, (ii) a sample tag region; and (iii) an anchor region.

### Claim 108 (depends on 107)

The kit of claim 107, wherein the amplification region comprises a polynucleotide sequence capable of serving as a primer recognition site for PCR amplification.

### Claim 109 (depends on 107)

The kit of claim 107, wherein the sample tag region identifies the test sample.

### Claim 110 (depends on 107)

The kit of claim 107, wherein the anchor region comprises a polynucleotide sequence that is capable of attaching to a DNA fragment.

### Claim 111 (depends on 106)

The kit of claim 106, wherein each adaptor of the set of adaptors is configured to attach to a DNA fragment of the plurality of DNA fragments to generate a DNA library comprising at least two unique sample tag regions, wherein each of the DNA library fragments comprises a DNA fragment attached to an adaptor.

### Claim 112 (depends on 106)

The kit of claim 106, wherein the test sample is a tissue biopsy.

### Claim 113 (depends on 106)

The kit of claim 106, wherein the DNA fragments are cell-free DNA (cfDNA) or cellular DNA.

### Claim 114 (depends on 106)

The kit of claim 106, wherein the DNA fragments are genomic DNA.

### Claim 115 (depends on 113)

The kit of claim 113, wherein the DNA fragments are isolated from the test sample; and wherein the test sample is a biological sample selected from the group consisting of: amniotic fluid, blood, plasma, serum, semen, lymphatic fluid, cerebral spinal fluid, ocular fluid, urine, saliva, stool, mucous, and sweat.

### Claim 116 (depends on 107)

The kit of claim 107, wherein the amplification region of each adaptor of the set of adaptors is identical to the amplification region of every other adaptor of the set of adaptors.

### Claim 117 (depends on 107)

The kit of claim 107, wherein the sample tag region identifies the DNA fragment attached thereto.

### Claim 118 (depends on 107)

The kit of claim 107, wherein each adaptor of the set of adaptors further comprises a unique molecule identifier multiplier (UMI multiplier) that is adjacent to or contained within the sample tag region.

### Claim 119 (depends on 107)

The kit of claim 107, wherein each adaptor of the set of adaptors further comprises a UMI multiplier which increases the number of unique sequences for identifying the plurality of DNA fragments.

### Claim 120 (depends on 106)

The kit of claim 106, wherein the pool of sample tag regions comprises between 2 and 1,000 unique sample tag region sequences.

### Claim 121 (depends on 106)

The kit of claim 106, further comprising one or more capture probe modules.

### Claim 122 (depends on 121)

The kit of claim 121, wherein each capture probe module comprises a tail sequence and a capture probe sequence capable of hybridizing to a target sequence in the test sample.

### Claim 123

A method for highly sensitive detection of copy number gain and copy number loss comprising:
(i) determining a raw genomic depth (RGD) for a capture probe;
(ii) normalizing the RGD for the capture probe across all samples in an experimental group by converting the RGD for the capture probe into a probe-specific, normalized read count;
(iii) calculating an approximate copy number value for each probe-specific, normalized read count; and
(iv) averaging the approximate copy number values for all probes that target a specific gene.

### Claim 124

A method for measuring chromosome stability comprising:
(i) designing and validating a set of one or more chromosomal stability probes, wherein the chromosomal stability probes are uniformly distributed across human chromosomes;
(ii) performing targeted sequencing on patient samples using the one or more chromosomal stability probes;
(iii) determining an approximate copy number value for each chromosomal probe;
(iv) determining a genomic phenotype of a patient sample, wherein fluctuations in the copy number values for one or more chromosomal probes in the patient sample indicate genomic instability.

### Claim 125

A DNA library, wherein the DNA library comprises a plurality of DNA library fragments, wherein each of the DNA library fragments comprises an adaptor and a DNA fragment,
wherein the adaptor is a DNA polynucleotide comprising (i) an amplification region, (ii) a sample tag region, and (iii) an anchor region;
wherein the amplification region comprises a polynucleotide sequence capable of serving as a primer recognition site for PCR amplification;
wherein the sample tag region identifies the test sample; and
wherein the anchor region comprises a polynucleotide sequence that is capable of attaching to a DNA fragment.

### Claim 126 (depends on 111)

A method for genetic analysis of a DNA target region comprising:
(a) generating a DNA library using the kit of claim 111, wherein the DNA library comprises cfDNA;
(b) contacting the DNA library with a plurality of capture probe modules that specifically bind to a DNA target region, thereby forming complexes between the capture probe modules and DNA library fragments comprising the DNA target region; and
(c) performing a quantitative genetic analysis of the DNA library fragments comprising the DNA target region;
thereby performing genetic analysis of the DNA target region.

### Claim 127 (depends on 111)

A method of predicting, diagnosing, or monitoring a genetic disease in a subject comprising:
(a) obtaining a test sample from a subject;
(b) isolating DNA from the test sample;
(c) generating a DNA library comprising a plurality of DNA library fragments using the kit of claim 111, wherein each of the DNA library fragments comprises a DNA fragment from the test sample and an adaptor;
(d) contacting the DNA library with a plurality of capture probe modules that specifically bind to a DNA target region, thereby forming complexes between the capture probe modules and DNA library fragments comprising the DNA target region; and
(e) performing a quantitative genetic analysis of one or more target genetic loci associated with the genetic disease in the DNA library, wherein the identification or detection of one or more genetic lesions in the one or more target genetic loci is prognostic for, diagnostic of, or monitors the progression of the genetic disease.

### Claim 128

A set of adaptors,
wherein each adaptor of the set of adaptors comprises a sample tag region selected from a pool of unique sample tag regions, wherein the pool is selected from a plurality of pools, and wherein the selected pool is unique to a test sample;
wherein each adaptor in said set of adapters is a DNA polynucleotide that comprises: an amplification region, a sample tag region, and an anchor region;
wherein the amplification region comprises a polynucleotide sequence capable of serving as a primer recognition site for PCR amplification;
wherein the sample tag region identifies the test sample; and
wherein the anchor region comprises a polynucleotide sequence that is capable of attaching to a DNA fragment.
